Robert M Cohen
Overview
Explore the profile of Robert M Cohen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
3780
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arbabi S, Smith E, Smith E, Fondriest J, Akeno N, Franco R, et al.
J Breath Res
. 2025 Feb;
19(2).
PMID: 39999479
The measurement of exhaled carbon monoxide (eCO) is relevant to understanding normal physiology and disease states but has been limited by deficiencies in valid sampling protocols, accurate and feasible measurement...
2.
Ehrmann D, Krause-Steinrauf H, Uschner D, Wen H, Hoogendoorn C, Crespo-Ramos G, et al.
Diabetologia
. 2025 Feb;
PMID: 39951058
Aims/hypothesis: Insulin resistance and inflammation are components of a biological framework that is hypothesised to be shared by type 2 diabetes and depression. However, depressive symptoms include a large heterogeneity...
3.
4.
Panwar A, Rentsendorj A, Jhun M, Cohen R, Cordner R, Gull N, et al.
Proc Natl Acad Sci U S A
. 2024 Jul;
121(29):e2401420121.
PMID: 38995966
Cerebral (Aβ) plaque and (pTau) tangle deposition are hallmarks of Alzheimer's disease (AD), yet are insufficient to confer complete AD-like neurodegeneration experimentally. Factors acting upstream of Aβ/pTau in AD remain...
5.
Shehab M, Cohen R, Brehm B, Bakas T
J Diabetes Sci Technol
. 2024 Apr;
:19322968241248606.
PMID: 38682598
Background: Patients with insulin-treated diabetes struggle with performing accurate carbohydrate counting for proper blood glucose control. Little is known about the comparative accuracy and feasibility of carbohydrate counting methods. Purpose:...
6.
Tozzo V, Genco M, Omololu S, Mow C, Patel H, Patel C, et al.
Diabetes Care
. 2024 Feb;
47(3):460-466.
PMID: 38394636
Objective: To examine the accuracy of different periods of continuous glucose monitoring (CGM), hemoglobin A1c (HbA1c), and their combination for estimating mean glycemia over 90 days (AG90). Research Design And...
7.
Hampe C, Shojaie A, Brooks-Worrell B, Dibay S, Utzschneider K, Kahn S, et al.
J Endocr Soc
. 2024 Feb;
8(3):bvad179.
PMID: 38333889
Context: Autoantibodies directed against the 65-kilodalton isoform of glutamic acid decarboxylase (GAD65Abs) are markers of autoimmune type 1 diabetes (T1D) but are also present in patients with Latent Autoimmune Diabetes...
8.
Panwar A, Rentsendorj A, Jhun M, Cohen R, Cordner R, Gull N, et al.
bioRxiv
. 2024 Feb;
PMID: 38328072
Significance Statement: This study changes our view of Alzheimer's Disease (AD) initiation and progression. Mutations promoting cerebral beta-amyloid (Aβ) deposition guarantee rare genetic forms of AD. Thus, the prevailing hypothesis...
9.
Garvey W, Cohen R, Butera N, Kazemi E, Younes N, Rosin S, et al.
Diabetes Care
. 2024 Jan;
47(4):562-570.
PMID: 38285957
Objective: To describe the individual and joint associations of baseline factors with glycemia, and also with differential effectiveness of medications added to metformin. Research Design And Methods: Glycemia Reduction Approaches...
10.
Rasouli N, Younes N, Ghosh A, Albu J, Cohen R, DeFronzo R, et al.
Diabetes Care
. 2024 Jan;
47(4):580-588.
PMID: 38211595
Objective: To compare the long-term effects of glucose-lowering medications (insulin glargine U-100, glimepiride, liraglutide, and sitagliptin) when added to metformin on insulin sensitivity and β-cell function. Research Design And Methods:...